Evidence map›Paper›PMID 35105655›Full record

ArticleBMJ open2022

Protocol for a single-centre mixed-method pre-post single-arm feasibility trial of a culturally appropriate 6-week pulmonary rehabilitation programme among adults with functionally limiting chronic respiratory diseases in Malawi.

Fanuel Meckson Bickton, Talumba Mankhokwe, Rebecca Nightingale, Cashon Fombe, Martha Mitengo, Langsfield Mwahimba, Wilfred Lipita, Laura Wilde, Ilaria Pina, Zainab K Yusuf and 13 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 2 countries.

Fanuel Meckson BicktonLung Health Research Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi fbickton@mlw.mw.ORCID 0000-0002-0925-909X
Talumba MankhokwePhysiotherapy Department, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Rebecca NightingaleLung Health Research Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Cashon FombePhysiotherapy Department, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Martha MitengoPhysiotherapy Department, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Langsfield MwahimbaPhysiotherapy Department, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Wilfred LipitaPhysiotherapy Department, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Laura WildeDepartment of Respiratory Sciences, University of Leicester, Leicester, Leicestershire, UK.ORCID 0000-0002-1404-6304
Ilaria PinaDepartment of Respiratory Sciences, University of Leicester, Leicester, Leicestershire, UK.
Zainab K YusufDepartment of Respiratory Sciences, University of Leicester, Leicester, Leicestershire, UK.ORCID 0000-0001-7859-5102
Zahira AhmedDepartment of Respiratory Sciences, University of Leicester, Leicester, Leicestershire, UK.
Martin KampondaMedicine Department, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Felix LimbaniLung Health Research Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Harriet ShannonUCL GOS Institute of Child Health, University College London, London, UK.
Enock ChisatiDepartment of Rehabilitation Sciences, Kamuzu University of Health Sciences, Blantyre, Malawi.
Andy BartonDepartment of Respiratory Sciences, University of Leicester, Leicester, Leicestershire, UK.
Robert C FreeDepartment of Respiratory Sciences, University of Leicester, Leicester, Leicestershire, UK.
Michael SteinerDepartment of Respiratory Sciences, University of Leicester, Leicester, Leicestershire, UK.
Jesse A MathesonDepartment of Economics, University of Sheffield, Sheffield, UK.
Adrian ManiseNIHR Leicester Biomedical Research Centre, University Hospitals of Leicester NHS Trust, Leicester, UK.
Sally J SinghDepartment of Respiratory Sciences, University of Leicester, Leicester, Leicestershire, UK.
Jamie RylanceLung Health Research Group, Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Mark OrmeDepartment of Respiratory Sciences, University of Leicester, Leicester, Leicestershire, UK.ORCID 0000-0003-4678-6574
University of Leicester · GBQueen Elizabeth Central Hospital · MWUniversity of Liverpool · GBKamuzu Central Hospital · MWUniversity College London · GBUniversity Hospitals of Leicester NHS Trust · GBUniversity of Sheffield · GB

Funding

Wellcome TrustWellcome Trust 221465/Z/20/Z
6 · The paper itself

Abstract

introductionMalawi has a substantial burden of chronic respiratory diseases (CRDs) which cause significant morbidity and loss of economic productivity, affecting patients, families and health systems. Pulmonary rehabilitation (PR) is a highly recommended non-pharmacological intervention in the clinical management of people with CRDs. However, Malawi lacks published evidence on the implementation of PR for people with CRDs. This trial will test the feasibility and acceptability of implementing a culturally appropriate hospital-based PR programme among adults with functionally limiting CRDs at Queen Elizabeth Central Hospital in Blantyre, Malawi. METHODS AND ANALYSIS: This is a single-centre mixed-methods pre-post single-arm feasibility trial. Ten patients aged ≥18 years, with a spirometry confirmed diagnosis of a CRD and breathlessness of ≥2 on the modified Medical Research Council dyspnoea scale, will be consecutively recruited. Their baseline lung function, exercise tolerance and health status will be assessed; including spirometry, Incremental Shuttle Walk Test and Chronic Obstructive Pulmonary Disease Assessment Test, respectively. Pretrial semistructured in-depth interviews will explore their experiences of living with CRD and potential enablers and barriers to their PR uptake. Along with international PR guidelines, these data will inform culturally appropriate delivery of PR. We initially propose a 6-week, twice-weekly, supervised centre-based PR programme, with an additional weekly home-based non-supervised session. Using combination of researcher observation, interaction with the participants, field notes and informal interviews with the participants, we will assess the feasibility of running the programme in the following areas: participants' recruitment, retention, engagement and protocol adherence. Following programme completion (after 6 weeks), repeat assessments of lung function, exercise tolerance and health status will be conducted. Quantitative changes in clinical outcomes will be described in relation to published minimal clinically important differences. Post-trial semistructured interviews will capture participants' perceived impact of the PR programme on their quality of life, enablers, and barriers to fully engaging with the programme, and allow iteration of its design. ETHICS AND DISSEMINATION: Ethical approval for this trial was obtained from University of Malawi College of Medicine Research and Ethics Committee (COMREC), Blantyre, Malawi (protocol number: P.07/19/2752) and University of Leicester Research Ethics Committee, Leicester, UK (ethics reference: 31574). The results of the trial will be disseminated through oral presentations at local and international scientific conferences or seminars and publication in a peer-reviewed journal. We will also engage the participants who complete the PR trial and the Science Communication Department at Malawi-Liverpool-Wellcome Trust Clinical Research Programme to organise community outreach activities within Blantyre to educate communities about CRDs and PR. We will also broadcast our trial results through national radio station programmes such as the weekly "Thanzi la Onse" (Health of All) programme by Times Radio Malawi. We will formally present our trial results to Blantyre District Health Office and Malawi Ministry of Health. TRIAL REGISTRATION NUMBER: ISRCTN13836793.

Indexed as

Pulmonary Disease, Chronic ObstructiveQuality of LifeAdolescentAdultExercise ToleranceFeasibility StudiesHumansMalawichronic airways diseaserehabilitation medicinerespiratory physiology

Identifiers

PMID35105655
PMCPMC8804676
OpenAlexW4210395867

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.